Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial
Verschueren, Patrick, De Cock, Diederik, Corluy, Luk, Joos, Rik, Langenaken, Christine, Taelman, Veerle, Raeman, Frank, Ravelingien, Isabelle, Vandevyvere, Klaas, Lenaerts, Jan, Geens, Elke, Geusens, Piet, Vanhoof, Johan, Durnez, Anne, Remans, Jan, Vander Cruyssen, Bert, Van Essche, Els, Sileghem, An, De Brabanter, Griet, Joly, Johan, Van der Elst, Kristien, Meyfroidt, Sabrina, Westhovens, Rene
Published in Arthritis research & therapy (09.04.2015)
Published in Arthritis research & therapy (09.04.2015)
Get full text
Journal Article